CSPI Expects Pfizer’s Centrum Claim Changes To Resonate Across Industry
This article was originally published in The Tan Sheet
Executive Summary
Pfizer will discontinue advertising claims for Centrum Ultra Women’s and Silver Women’s multivitamin supplements for “breast health” and Centrum Ultra Men’s and Silver Ultra Men’s for “colon health.”
You may also be interested in...
Regulatory News In Brief
GSK pays GMP whistleblower fine
Pharmavite Amends CholestOff Claims After FTC Joins Heart Health Hunt
An attorney for Pharmavite questions federal regulators' apparent pursuit of cholesterol-lowering products after the firm satisfies a Federal Trade Commission investigation by revising marketing language for its CholestOff dietary supplement
People In Brief
Herbalife brings on Dentali as botanical sciences VP; NACDS expands Nicholson’s role; Innophos announces interim CFO; George Hamilton new face of Infusion Life Sciences; Aker BioMarine names sales VP; Atteryd to chair Food Supplements Europe.